Bibliografia
Tanko LB, Christiansen C, Cox DA et al. (2005) Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 20(11):1912–1920
Mazziotti G, Tupputi U, Ferrante G, Guglielmi G (2020) Abdominal aortic calcification as a marker of relationship between atherosclerosis and skeletal fragility. J Clin Densitom 23(4):539–542
Langdahl BL, Hofbauer LC, Forfar JC (2021) Cardiovascular safety and sclerostin inhibition. J Clin Endocrinol Metab 106(7):1845–1853
EMA (2020) Evenity (romosozumab) 2020. https://www.ema.europa.eu/en/medicines/human/EPAR/evenity. Accessed on 23 September 2022
Laroche M, Pecourneau V, Blain H et al. (2017) Osteoporosis and ischemic cardiovascular disease. Jt Bone Spine 84(4):427–432
Pineda-Moncusí M, El-Hussein L, Delmestri A et al. (2022) Estimating the incidence and key risk factors of cardiovascular disease in patients at high risk of imminent fracture using routinely collected real-world data from the UK. J Bone Miner Res 37(10):1986–1996
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Nota della casa editrice
Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.
Rights and permissions
About this article
Cite this article
Jaafar, S., Mazziotti, G. Il rischio cardiovascolare nei pazienti con osteoporosi conclamata. L'Endocrinologo 24, 103–104 (2023). https://doi.org/10.1007/s40619-023-01220-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40619-023-01220-x